Home > Insider Trading > Filing (0001415889-25-013726)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
856982	Merit Medical Systems Inc	MMSI	Surgical & Medical Instruments & Apparatus (3841)	870447695

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1649014	Ann F. Millner	1600 West Merit Parkway South Jordan UT 84095		No	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock, No Par Value	Acquisiton	2025-05-15	2,152	$0.00	34,543	No	4	A	Direct
Common Stock, No Par Value	Acquisiton	2025-05-15	21,250	$52.17	55,793	No	4	M	Direct
Common Stock, No Par Value	Disposition	2025-05-15	21,250	$96.47	34,543	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	A	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Non-qualified stock options (right to buy)	Disposition	2025-05-15	13,750	$0.00	13,750	$52.17
Common Stock	Non-qualified stock options (right to buy)	Disposition	2025-05-15	7,500	$0.00	7,500	$52.17

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2020-05-24	2026-05-24	No	4	M	Direct
0	2020-05-31	2026-05-31	No	4	M	Direct

Footnotes

The reported transaction involved the reporting person's receipt of a grant of 2,152 restricted stock units (RSUs) under the Merit Medical Systems, Inc. 2018 Long-Term Incentive Plan. The RSUs vest on May 15, 2026. Vesting of the RSUs is subject to continued service to the issuer through the vesting date.
The acquisition of shares pursuant to an outstanding option and sale of those shares were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan adopted on August 7, 2023.
The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $96.16 to $97.16, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
Becomes exercisable in equal annual installments of 33% commencing 05/24/2020.
Becomes exercisable in equal annual installments of 33% commencing 05/31/2020.